Skip to content

Public FDA record

Z-3022-2018: ev3 TurboHawk PERPHERAL PLAQUE EXCISION SYSTEM FOR SURGICAL USE, LARGE VESSEL XTENDED TIP FOR CALCIUM, Mo

Recall record Z-3022-2018 for Micro Therapeutics Inc, Dba Ev3 Neurovascular. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-3022-2018
Company in FDA record
Micro Therapeutics Inc, Dba Ev3 Neurovascular
FDA record creation date
Sep 11, 2018
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The Distal Flush Tool (DFT) accessories that were packaged in this lot number are not compatible with the TurboHawk LX-C catheter. This may result in the inability to remove excised material from the tip of the catheter.

Source facts

Action
Medtronic began notifying the Consignees on 10-Aug-2018. Consignees were asked to quarantine and return affected product.
Initiated
2018-08-10
Root cause
Process control
Terminated
2020-08-04
Distribution
Distribution to US states of KS, CA, FL, GA, AZ, MI, LA, TX, NE, KY, and China
Recall number
Z-3022-2018
Recall status
Terminated
CDRH record ID
166684
FDA record created
2018-09-11
Recall event number
80831

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗